3 New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu Jul 04, 2023
Read More Medical Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives! Dec 12, 2024
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Dec 04, 2024
